Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole

Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole

Author Pacheco, P. A. Google Scholar
Rodrigues, Letícia Norma Carpentieri Autor UNIFESP Google Scholar
Ferreira, J. F. S. Google Scholar
Gomes, A. C. P. Google Scholar
Verissimo, C. J. Google Scholar
Louvandini, H. Google Scholar
Costa, R. L. D. Google Scholar
Katiki, L. M. Google Scholar
Abstract Albendazole (ABZ), a benzimidazole widely used to control gastrointestinal parasites, is poorly soluble in water, resulting in variable and incomplete bioavailability. This has favored the appearance ABZ-resistant nematodes and, consequently, an increase in its clinical ineffectiveness. Among the pharmaceutical techniques developed to increase drug efficacy, cyclodextrins (CDs) and other polymers have been extensively used with water-insoluble pharmaceutical drugs to increase their solubility and availability. Our objective was to prepare ABZ formulations, including beta-cyclodextrin (beta CD) or hydroxypropyl-beta-cyclodextrin (HP beta CD), associated or not to the water-soluble polymer polyvinylpyrrolidone (PVP). These formulations had their solubility and anthelmintic effect both evaluated in vitro. Also, their anthelmintic efficacy was evaluated in lambs naturally infected with gastrointestinal nematodes (GIN) through the fecal egg count (FEC) reduction test. In vitro, the complex ABZ/HP beta CD had higher solubility than ABZ/beta CD. The addition of PVP to the complexes increased solubility and dissolution rates more effectively for ABZ/HP beta CD than for ABZ/beta CD. In vivo, 48 lambs naturally infected with GIN were divided into six experimental groups: control, ABZ, ABZ/beta CD, ABZ/beta CD-PVP, ABZ/HP beta CD, and ABZ/HP beta CD-PVP. Each treated animal received 10 mg/kg of body weight (based on the ABZ dose) for three consecutive days. After 10 days of the last administered dose, treatment efficacy was calculated. The efficacy values were as follows: ABZ (70.33%), ABZ/beta CD (85.33%), ABZ/beta CD-PVP (82.86%), ABZ/HP beta CD (78.37%), and ABZ/HP beta CD-PVP (43.79%). In vitro, ABZ/HP beta CD and ABZ/HP beta CD-PVP had high solubility and dissolution rates. In vivo, although the efficacies of ABZ/beta CD, ABZ/beta CD-PVP, and ABZ/HP beta CD increased slightly when compared to pure ABZ, this increase was not significant (P > 0.05).
Keywords Albendazole
Inclusion complex
xmlui.dri2xhtml.METS-1.0.item-coverage New York
Language English
Sponsor Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) |Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)
Grant number FAPESP: 2013/15704-3
Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior
Date 2018
Published in Parasitology Research. New York, v. 117, n. 3, p. 705-712, 2018.
ISSN 0932-0113 (Sherpa/Romeo, impact factor)
Publisher Springer
Extent 705-712
Access rights Closed access
Type Article
Web of Science ID WOS:000426550800008

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account